Starting with the complex, detailed description of a system, dimensional analysis searches for the simplest mathematical form to represent the real system (Deen, 1998) . In complex systems, dimensional analysis can usually result in a dramatic simplification of the problem. A side effect of performing the dimensional analysis is that during the process, the parameters in the system automatically rearrange into groups of parameters, called the dimensionless groups. The number of dimensionless groups indicates the degrees of the freedom in the system, and is often smaller than the actual number of physical parameters. A well-known example of a dimensionless group is the Reynolds number.
Let X be a variable in the system. We will search for a scale X 0 , which has the same unit as X, and define the dimensionless variable x as
In practice, a variable is appropriately scaled if its maximum value is not too small (<0.1) or too large (>10).
The scale X 0 can be found using the order-of-magnitude analysis (Deen, 1998 ), which we illustrate next. As will become apparent shortly, this process involves some guessing and intuitive reasoning about how the system operates. One control for this process is self-consistency. There can be several appropriate scales for a given variable. If we derive a "wrong" scale, the scaled variable will simply be either very large (>10) or very small (<0.1), i.e., not in the order of 1.
But in general, we can scale the problem any way we like; some scales may yield more insights than others, depending on the questions we ask.
Our starting point was a system of 7 ordinary differential equations (ODEs) and 8 algebraic equations, derived in (Lee et al., 2003) . The dimensional analysis could have been performed on the original problem of 15 ODEs; With respect to steady-state solutions, we will obtain the same results. To facilitate the discussion, the 7 ODEs are reproduced here: 
where the parameters are defined in Figure 2A , and the variables are: Finding Concentration Scales: Order-of-Magnitude Analysis
Variables Component
As an illustration, we now derive the concentration scale for β-catenin, X 110 . The most intuitive guess is that the concentration of β-catenin scales with its steadystate value. Let us set eqn. 7 to zero, and solve for X 11 ,
We make a guess that β-catenin scales with its steady-state value, 
where X 30 is the scale for X 3 ,
Since we have a sense that the rate of non-Axin-dependent degradation << rate of Axin-dependent degradation,
we can safely simplify eqn. 9 to,
To further support our intuition, from the Xenopus parameters, 
10
-3 + 10 -4 ~ 10 -3 .
To fully derive the concentration scale of β-catenin, we need to find X 30 . We find X 30 using a similar procedure:
(1) Estimate the order of magnitude of APC*/axin*/GSK3 concentration (X 3 ) at steady state (set equations 2,4-6 to zero) (2) Perform an order-of-magnitude substitution (as in eqn. 9) (3) Drop the small terms (as in eqns. 11)
If we "mistakenly" drop terms, we will simply get an inappropriate scaling. In which case, we go back to the order-of-magnitude analysis and try keeping or dropping another term, until we find the appropriate concentration scales that make the scaled variable ~ 1.
After some algebraic steps, we have the following expression for X 30 , 
Substituting eqn. 12 into eqn. 11, we have the concentration scale for β-catenin.
Performing, the order-of-magnitude analysis for the other variables, we obtain the following concentration scales: 
Let us define x 11 as the dimensionless β-catenin concentration,
where X 11 is β-catenin concentration, X 110 is the concentration scale of β-catenin.
Similarly, we define x 3 as the dimensionless APC*/Axin*/GSK3 concentration. 
Let us rearrange eqn. 14 into its simplest form, by dividing both sides with 
Let us now define the following dimensionless groups, 
The four dimensionless groups describing the system are: 
Dimensionless groups Definition
With respect to β-catenin. the groups δ 1 and δ 2 merge further:
The original problem (eqns. 1-7) has been systematically rescaled such that scaled variables are now in the order of 1. In the process, the numerous parameters automatically rearrange into 4 groups of parameters.
Each parameter in the model corresponds to a physical, measurable parameter (e.g., protein concentration, rate constants, equilibrium constant, etc.), describing interactions known to take place in the Wnt pathway. Dimensional analysis reveals that many of these parameters affect the system in the same way: there are only 4 independent ways to perturb the model of the Wnt pathway at steady state. We now derive an analytical solution for the model.
Steady-State Solution of the Model of the Wnt Pathway
We now solve the scaled model (eqns. 18-24) for:
(1) The steady-state level of β-catenin (2) The Wnt-induced fold-change in β-catenin From eqn. 18, the steady-state ODE describing β-catenin is
To solve for β-catenin (x 11 ), we derive x 3 from eqns. 19-24, ( )
Substituting eqn. 25 into eqn. 18,
After a series of algebraic steps, eqn. 26 simplifies into a quadratic form, Incorporating the Dual role of APC (Takacs et al., 2008) It was recently shown that APC has a negative role (promoting degradation of β-catenin) and a positive role in Wnt signaling. APC most likely promotes degradation of Axin. This interaction was considered in the published study by (Lee et al., 2003) (Figure 5 and eqn. 5). In the present analysis, this addition simply leads to extra parameters in α.
Current model:
With APC promoting degradation of Axin: The remaining analysis remains the same, just a re-definition of α.
Understanding the Mechanism of Robustness Using Separation of Timescale
To gain more insights, we derive an approximate description of β-catenin accumulation by using separation of time scales in the system. Because of the slow DC-independent degradation, β-catenin is the sluggish component in the system. (DC is short for destruction complex, APC/Axin/GSK3) The other six independent variables reach steady state relatively rapidly, and are subsequently slaved by the slow dynamics of β-catenin, until the level of β-catenin reaches a steady state a few hours later.
The ODE describing β-catenin dynamics is given in eqn. 7, ( ) ( ) 
Setting 0 
where X 30 is the concentration scale for X 3 , as derived in the previous section.
Substituting eqn. 34 into eqn. 33,
The denominator in eqn. 35 is only significantly different from 1 within the initial transient period. Since we are examining the behavior at and near steady state here, it can therefore be set to 1.
We are left with the following dimensional, approximate equation describing β-catenin dynamics, 
where X 110 is the concentration scale for β-catenin derived in the previous section, and k 13 is the rate constant of DC-independent degradation of β-catenin (this is the slow step in b-catenin dynamics).
Substituting the scaled variables, and the dimensionless groups defined in the previous section, we obtain the dimensionless, approximate ODE of β-catenin dynamics: The dynamics of β-catenin is affected by an effective production term and two degradation terms: the DC-dependent degradation (regulated by ligand, represented by the dimensionless group δ) and the DC-independent degradation.
The binding between β-catenin and APC (reaction 17) appears as a positive feedback term in eqn. 38: it inhibits the DC-dependent degradation term. In the Xenopus system, binding between β-catenin and APC is weak (K d~1 000nM). But under appropriate condition (when γ/α is large enough), this interaction can act as a positive feedback: β-catenin sequesters APC, amplifying the effects of Wnt in inactivating the destruction complex. (Notice that it is not enough to simply make the binding stronger, equivalent to increasing γ, but α also has to be smaller than γ for the positive feedback to appear).
Effective production term
(the synthesis rate is "scaled out") DC-dependent degradation (Ligand-regulated)
DC-independent degradation
Positive feedback term (~β-cat-APC binding) 
The fold-change in β-catenin is in general a function of all three groups of parameters, α, β, and γ. However, as shown in Figure 3B , there is a region of parameters where the fold-change in β-catenin is insensitive to variation in the dimensionless groups α and γ. This region is located where α >> 1 and γ << 1.
Applying these conditions reduces eqn. 38 to:
and the Wnt-induced fold-change in β-catenin becomes independent of α and γ,
(the same result is obtained if we apply the conditions α >> 1 and γ << 1 directly to eqn. 30).
Within the insensitive region of parameters, two terms drop out from eqn. 38:
1. The DC-independent degradation 2. The positive feedback term (the APC-β-catenin binding) and eqn. 38 reduces to a simple balance of production and degradation.
The fold-change in β-catenin is insensitive to variation in most parameters within the pathway, and a function of the ligand-containing terms only, if the DCdependent degradation proceeds very rapidly (by more than 10-fold faster than other processes in the pathway). This is by no means trivial since it requires a very rapid cycle of binding, phosphorylation, and dissociation. As a result, the DC-dependent degradation dominates over other routes for degrading β-catenin and renders the positive feedback interaction negligible. Figure S1 . Other Features of β-Catenin Accumulation Are Sensitive to Parameters Figure S2 . The Insensitivity to Parameters Can Still Be Seen when the Total Pool of β-Catenin (the Measurable Quantity) Is Examined Instead Same as Figure S1 , except that the total pool of β-catenin is plotted here, as opposed to free, un-phosphorylated β-catenin in Figure  S1 . The total pool of β-catenin is the quantity that can be measured using Western blot.
Figure S3. Sensitivity to Ligand Concentration
As a control, the basal level of β-catenin is not affected by variations in δ (~ligand stimulation). The Wnt-induced level and fold-change in β-catenin is sensitive to δ. The higher γ (~higher Wnt concentration), the higher the Wnt-induced level of β-catenin, and consequently the fold-change in β-catenin. γ=1 is used in these calculations. Figure S4 . Experimental Protocol of the Inhibitor Treatment RKO cells were pre-treated with different doses of LiCl (0-80mM) for 3h (in growth media). After that, the cells were transferred into control media or Wnt3A-conditioned media (WCM) + 0-80mM lithium. Cells were harvested usually at 24h, lysed, and analyzed using dot blot. β-catenin (-Wnt) = level of β-catenin in cells incubated in control media + 0-80mM lithium. This normally changed little from 0h onward (i.e., the effects of lithium equilibrated rapidly). β-catenin (+Wnt) = level of β-catenin in cells incubated in WCM + 0-80mM lithium after the new plateau in β-catenin was reached. The time to reach the new Wnt-induced plateau varied from ~3h (in untreated cells) to ~20-24h (in cells treated with the highest dose of lithium). It was most efficient to harvest all cells at the same time and it gave the same result as when the cells were harvested as soon as β-catenin reached the new plateau. Wnt-induced fold-change in β-catenin = β-cat (+Wnt) / Basal β-cat (-Wnt) Control media: Using DMEM+serum or L-cell-conditioned media gave the same results. L cell line is the parental line for the L-Wnt3A cell line. Pre-treatment period: 3h or 6h pre-treatment gave the same result. The same protocol was used for BIO treatment. Cells were pre-incubated with BIO for 3 hours, followed by Wnt treatment in the presence of BIO for 6-24 hours. The level of β-catenin was quantified using dot blot. As a negative control, treatment with DMSO or MeBIO gave no significant changes in the level of β-catenin.
Figure S7. More on Inhibiting GSK3β in Cells Overexpressing β-Catenin
These measurements were performed in the same experiment, side by side. For each data point, 2 biological replicates were examined; SD is the std. dev. from 3 independent dot blots. In the main text, these data are included in Figures 4E-G. Here, they are presented side by side to show more directly that: 1) Cells overexpressing β-catenin responded more to Wnt stimulation (i.e., gave a higher fold-change).
2) Cells overexpressing β-catenin were less buffered when treated with lithium (i.e., fold-change decreased more readily). More repeat experiments are shown in the main text. Figure S8. Step-by-Step Details on How Figure 5A Was Generated To illustrate how Figure 5A was generated, let us decrease α from the Xenopus setpoint. As depicted by the green arrow in Figure A , the basal level of β-catenin will increase whereas the Wnt-induced fold-change in β-catenin will remain constant initially. As shown in Figure B , we then plot independently β-catenin level and fold-change as a function of α. Figure S10 . Separating Cadherin-Bound Pool of β-Catenin (A) To separate the cadherin-bound pool of β-catenin, a standard protocol was followed (Guger and Gumbiner, 2000; McCrea et al., 1991) . 100 uL of embryo lysates (10 embryos) were rotated at 4 o C for 1h with 100uL Concanavalin A-Sepharose 4B slurry (Sigma C9017). Supernatant and beads were separated by centrifugation (three 5min spin at 16,000g). (B) The supernatant showed trace bands with monoclonal anti-cadherin 6B6 (Hybridoma Bank, 1:500). The 6B6 detects C-/U-/EP-cadherin, the cadherins expressed in early embryos (Heasman et al., 1994) . The lower bands (<100kDa) are likely to be cadherin degradation products because they disappear with RIPA-extraction. At all stages measured, β-catenin mRNA injection has lower effect on β-catenin protein level, and yet gives more severe phenotypes. Figure S13 . Transcription Is Not Saturated Table S1 .
Complete Data from Experiments in

Xenopus laevis
Controls are sibling embryos from the same mother and fertilization. Amount of RNA is a rough estimate. To get a dose-response, the same RNA stock solution was diluted in different volumes of nuclease-free water. In most experiments, all embryos were photographed and re-scored blindly on different days (the photos are available upon request); the results were similar. Different experiments were days to weeks apart; multiple females were used in an experiment. 
Negative control: Bias due to expectation to see effects
In these experiments, we injected trace amount of β-catenin mRNA without realizing it was a trace amount (a 10-fold mistake in dilution). The mistake was not discovered until we performed scoring and Western blots. The result was a negative control that allowed us to examine the expectation bias in scoring and measurements.
Exp 10
Control 54 
